Relationship among hormonal treatments, suppression of spermatogenesis, and testicular protection from chemotherapy-induced damage

Endocrinology

Volumn 137, Issue 9, 1996, Pages 3823-3831

  Meistrich, Marvin L ^a,d   Wilson, Gene ^a   Ye, Wei San ^a,e   Thrash, Candace ^b   Huhtaniemi, Ilpo ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LUTEINIZING HORMONE; PROCARBAZINE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; DOSE RESPONSE; HODGKIN DISEASE; HORMONE SUBSTITUTION; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SERTOLI CELL; SPERMATOGENESIS; SPERMATOGONIUM; SPERMATOZOON COUNT; TESTIS INJURY; TESTOSTERONE RELEASE;

EID: 0029814864     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.9.8756553     Document Type: Article

References (39)

1. da Cunha MF, Meistrich ML, Fuller LM, Cundiff JH, Hagemeister FB, Velasquez WS, MacLaughlin P, Riggs SA, Cabanillas FF, Salvador PG 1984 Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy. J Clin Oncol 2:571-577
2. Delic JI, Bush C, Peckham MJ 1986 Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen. Cancer Res 46:1909-1914
3. Delic JI, Harwood JR, Stanley JA 1987 Time dependence for the protective effect of androgen from procarbazine-induced damage to rat spermatogenesis. Cancer Res 47:1344-1347
4. Glode LM, Shannon JM, Malik N, Nett T 1990 Protection of rat spermatatogenic epithelium from damage induced by procarbazine chemotherapy. Br J Cancer 62:61-64
5. Jegou B, Velez de la Calle JF, Bauche F 1991 Protective effect of medroxy-progesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring. Proc Natl Acad Sci USA 88:8710-8714
6. 1 hybrid rats. J Androl 14:257-266
7. Meistrich ML, Wilson G, Ye W-S, Kurdoglu B, Parchuri N, Terry NHA 1994 Hormonal protection from procarbazine-induced testicular damage is selective for survival and recovery of stem spermatogonia. Cancer Res 54:1027-1034
8. Weissenberg R, Lahav M, Raanani P, Singer R, Regev A, Sagiv M, Giler S, Theodor E 1995 Clomiphene citrate reduces procarbazine-induced sterility in a rat model. Br J Cancer 71:48-51
9. Ward JA, Robinson J, Furr BJA, Shalet SM, Morris ID 1990 Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist. Cancer Res 50:568-574
10. Kangasniemi M, Wilson G, Huhtaniemi I, Meistrich ML 1995 Protection against procarbazine-induced testicular damage by GnRH-agonist and anti-androgen treatment in the rat. Endocrinology 136:3677-3680
11. Kangasniemi M, Wilson G, Parchuri N, Huhtaniemi I, Meistrich ML 1995 Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide). Endocrinology 136:2881-2888
12. Glode LM, Robinson J, Gould SF 1981 Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet 1:1132-1134
13. Clermont Y, Harvey SC 1965 Duration of the cycle of the seminiferous epithelium of normal hypophysectomized and hypophysectomized-hormone treated albino rats. Endocrinology 76:80-89
14. Ewing LL, Desjardins C, Irby DC, Robaire B 1977 Synergistic interaction of testosterone and oestradiol inhibits spermatogenesis in rats. Nature 269:409-411
15. Haavisto A, Pettersson K, Bergendahl M, Perheentupa A, Roser JF, Huhtaniemi I 1993 A supersensitive immunofluorometric assay for rat luteinizing hormone. Endocrinology 132:1687-1691
16. Clayton RN, Katikineni M, Chan V, Dufau ML, Catt KJ 1980 Direct inhibition of testicular function by gonadotropin-releasing hormone: Mediation by specific gonadotropin-releasing hormone receptors in interstitial cells. Proc Natl Acad Sci USA 77:4459-4463
17. Meistrich ML, Finch M, da Cunha MF, Hacker U, Au WW 1982 Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res 42:122-131
18. Meistrich ML, van Beek MEAB 1993 Spermatogonial stem cells: Assessing their survival and ability to produce differentiated cells. In: Chapin RE, Heindel J (eds) Methods in Reproductive Toxicology. Academic Press, New York, vol 3A:106-123
19. Zirkin BR, Santulli R, Awoniyi CA, Ewing LL 1989 Maintenance of advanced spermatogenic cells in the adult rat testis. Endocrinology 124:3043-3049
20. Robaire B, Ewing LL, Irby DC, Desjardins C 1979 Interactions of testosterone and estradiol-17 on the reproductive tract of the male rat. Biol Reprod 21:455-463
21. Ward JA, Furr BJA, Valcaccia B, Curry B, Bardin CW, Gunsalus GL, Morris ID 1989 Prolonged suppression of rat testis function by a depot formulation of Zoladex, a GnRH agonist. J Androl 10:478-486
22. Perheentupa A, Huhtaniemi I 1990 Gonadotropin gene expression and secretion in gonadotropin-releasing hormone antagonist-treated male rats: effects of sex steroid replacement. Endocrinology 126:3204-3209
23. Perheentupa A, de Jong F, Huhtaniemi I 1993 Biphasic effect of exogenous testosterone on follicle-stimulating hormone gene expression and synthesis in the male rat. Mol Cell Endocrinol 93:135-141
24. Chowdhury M, Tcholakian RK, Steinberger E 1980 Reevaluation of effects of estradiol benzoate on the production of testosterone and luteinizing hormone in the rat. Endocrinology 106:1311-1316
25. MacCalman CD, Blaschuk OW 1994 Gonadal steroids regulate N-cadherin mRNA levels in the mouse testis. Endocrine J 2:157-163
26. 1 rat. Biol Reprod 54:1200-1208
27. Jegou B 1993 The Sertoli-germ cell communication network in mammals. Int Rev Cytol 147:25-96
28. Gerard N, Syed V, Jegou B 1992 Lipopolysaccharide, latex beads and residual bodies are potent activators of Sertoli cell interleukin-lalpha production. Biochem Biophys Res Commun 185:154-161
29. McLachlan RI, Wreford NG, Meachem SJ, de Kretser DM, Robertson DM 1994 Effects of testosterone on spermatogenic cell populations in the adult rat. Biol Reprod 51:945-955
30. Bremner WJ, Millar MR, Sharpe RM, Saunders PTK 1994 Immunohistochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens. Endocrinology 135:1227-1234
31. Vomberger W, Prins G, Musto NA, Suarez-Quian CA 1994 Androgen receptor distribution in rat testis: new implications for androgen regulation of spermatogenesis. Endocrinology 134:2307-2316
32. Skinner MK, McLachlan RI, Bremner WJ 1989 Stimulation of Sertoli inhibin secretion by the testicular paracrine factor PModS. Mol Cell Endocrinol 66:239-249
33. Pogach LM, Lee Y, Gould S, Giglio W, Huang HFS 1988 Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration. Cancer Res 48:4354-4360
34. Keeney DS, Mendis-Handagama SMLC, Zirkin BR, Ewing LL 1988 Effect of long term deprivation of luteinizing hormone on Leydig cell volume, Leydig cell number, and steroidogenic capacity of the rat testis. Endocrinology 123:2906-2915
35. Morris ID, Shalet SM 1990 Protection of gonadal function from cytotoxic chemotherapy and irradiation. Ballieres Clin Endocrinol Metab 4:97-118
36. Brennemann W, Brensing KA, Leipner N, Boldt I, Klingmuller D 1994 Attempted protection of spermatogenesis from irradiation in patients with seminoma by D-tryptophan-6 luteinizing hormone releasing hormone. Clin Invest 72:838-842
37. Johnson DH, Linde R, Hainsworth JD, Vale W, Rivier J, Stein R, Flexner J, Welch RV, Greco FA 1985 Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations. Blood 65:832-836
38. Michel E, Bents H, Akhtar FB, Honigl W, Knuth UA, Sandow J, Nieschlag E 1985 Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility. Clin Endocrinol 23:663-675
39. Pavlou SN, Interlandi JW, Wakefield G, Rivier J, Vale W, Rabin D 1986 Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone. J Androl 7:228-233